Financial Results
Adeshwar Meditex Approves H1 FY27 Results
Adeshwar Meditex approved standalone unaudited financial results for the half year ended September 30, 2026, along with the internal audit report.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
3
Neutral
8
Bullish
3
Bearish
15
Neutral
20
Bullish
11
Bearish
12
Neutral
12
Bullish
8
Bearish
12
Neutral
12
Bullish
8
Bearish
12
Neutral
12
Bullish
8
Bearish
12
Neutral
12
Bullish
8
Financial Results
Adeshwar Meditex approved standalone unaudited financial results for the half year ended September 30, 2026, along with the internal audit report.
Board Meeting
Adeshwar Meditex will hold a board meeting on November 12, 2026, to consider standalone unaudited results for the quarter and half year ended September 30, 2026.
Adeshwar Meditex Ltd (ADESHWAR) is currently trading at 17.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Adeshwar Meditex Limited is a major manufacturer and exporter specializing in sterile surgical wound dressings and medical disposables. The company, established in 2007 and public since 2021, provides a wide range of medical items including first aid kits tailored for hospitals and diverse industries. Adeshwar Meditex's product portfolio includes military and orthopedic dressings, surgical gloves, medical bandages, and a variety of kits including HIV and PPE kits. The company emphasizes its role as a comprehensive solutions provider, engaging in multiple facets of manufacturing, import-export, and distribution. Adeshwar Meditex operates within domestic and international markets, catering to healthcare, military, and industrial sectors with its medical and surgical offerings.
Over the past 52 weeks, Adeshwar Meditex Ltd has traded between a low of ₹13.00 and a high of ₹21.70. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Adeshwar Meditex Ltd has a market capitalization of approximately 24.53. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Adeshwar Meditex Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 19.47 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 24.53 Cr, Adeshwar Meditex Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Adeshwar Meditex Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Adeshwar Meditex Ltd is 19.47. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Adeshwar Meditex reported Rs 4.4212 crore of net cash from operating activities for the half year ended September 30, 2026. Cash from operations before taxes was Rs 4.6412 crore, and the company paid Rs 22 lakh in taxes during the period.
Adeshwar Meditex reported net profit of Rs 52.09 lakh for the half year ended 30 September 2026. This was 29% below Rs 73.10 lakh reported in the corresponding half year ended 30 September 2025. Basic EPS declined to Rs 0.39 from Rs 0.51.
Adeshwar Meditex has scheduled its next disclosed board meeting for November 12, 2026. The board will consider and approve standalone unaudited results for the quarter and half year ended September 30, 2026.

Healthcare Services
Healthcare Research, Analytics & Technology
25 Cr
Low Risk
19.5
59.5
-0.4
0.6
21.70
13.00
Sales CAGR
Profit CAGR
ROE
ROCE